BioNexus Gene Lab Corp. (BGLC)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$2.40
+13.27%
Mkt Cap $4.02M
No analyst coverage available
We don't have analyst ratings or price target data for BioNexus Gene Lab Corp. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.